{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:07:45Z","timestamp":1788584865078,"version":"build-2803163510"},"reference-count":30,"publisher":"FapUNIFESP (SciELO)","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  BACKGROUND  Glycogen storage disease (GSD) type 1b is a multisystemic disease in which immune and infectious complications are present, in addition to the well-known metabolic manifestations of GSD. Treatment with granulocyte-colony stimulating factor (G-CSF) is often indicated in the management of neutropenia and inflammatory bowel disease.  OBJECTIVE  To report on the demographics, genotype, clinical presentation, management, and complications of pediatric patients with glycogen storage disease type 1b (GSD 1b), with special attention to immune-related complications.  METHODS  Retrospective case series of seven patients with GSD 1b diagnosed and followed at a tertiary university hospital in Brazil, from July\/2000 until July\/2016.  RESULTS  Mean age at referral was fourteen months. Diagnosis of GSD 1b was based on clinical and laboratory findings and supported by genetic studies in five cases. All patients presented suffered from neutropenia, managed with G-CSF - specifically Filgrastim. Hospitalizations for infections were frequent. Two patients developed inflammatory bowel disease. Six patients remained alive, one died at age 14 years and 9 months. The mean age at the end of the follow-up was 11.5 years. Compliance to treatment was suboptimal: poor compliance to medications, starch and dietetic management of GSD were documented, and outpatient appointments were frequently missed.  CONCLUSION  Managing GSD 1b is challenging not only for the chronic and multisystemic nature of this disease, but also for the additional demands related dietary restrictions, use of multiple medications and the need for frequent follow-up visits; furthermore in Brazil, the difficulties are increased in a scenario where we frequently care for patients with unfavorable socioeconomic status and with irregular supply of medications in the public health system.<\/jats:p>","DOI":"10.1590\/s0004-2803.202100000-15","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T12:33:55Z","timestamp":1619181235000},"page":"87-92","source":"Crossref","is-referenced-by-count":2,"title":["LONG TERM MANAGEMENT OF GLYCOGEN STORAGE DISEASE TYPE 1B: A BRAZILIAN TERTIARY CENTER EXPERIENCE"],"prefix":"10.1590","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9430-7817","authenticated-orcid":false,"given":"Marina Mayumi Vendrame","family":"TAKAO","sequence":"first","affiliation":[{"name":"Universidade Estadual de Campinas (Unicamp),  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7744-8984","authenticated-orcid":false,"given":"Natascha Silva","family":"SANDY","sequence":"additional","affiliation":[{"name":"University of Toronto,  Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1330-3591","authenticated-orcid":false,"given":"Adriana Gut Lopes","family":"RICCETTO","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas (Unicamp),  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7077-9804","authenticated-orcid":false,"given":"Adriana Maria Alves DE","family":"TOMMASO","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Campinas (Unicamp),  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2021,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10545-014-9772-x","article-title":"Type I glycogen storage diseases: disorders of the glucose-6-phosphatase\/glucose-6-phosphate transporter complexes","volume":"38","author":"Chou JY","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/humu.20772","article-title":"Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease","volume":"29","author":"Chou JY","year":"2008","journal-title":"Hum Mutat"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s100380170102","article-title":"Glycogen storage disease type Ia: molecular study in Brazilian patients","volume":"46","author":"de CRF","year":"2001","journal-title":"J Hum Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jped.2014.02.005","article-title":"Glycogen storage disease type I: clinical and laboratory profile","volume":"90","author":"Santos BL","year":"2014","journal-title":"J Pediatr"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00431-005-1657-4","article-title":"Genotype\/phenotype correlation in glycogen storage disease type 1b: a multicentre study and review of the literature","volume":"164","author":"Melis D","year":"2005","journal-title":"Eur J Pediatr"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MOH.0b013e328331df85","article-title":"Neutropenia in type Ib glycogen storage disease","volume":"17","author":"Chou JY","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1182\/blood-2013-05-502435","article-title":"Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib","volume":"123","author":"Jun HS","year":"2014","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1067\/mpd.2000.105232","article-title":"Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I","volume":"137","author":"Visser G","year":"2000","journal-title":"J Pediatr"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3343\/alm.2017.37.3.261","article-title":"Novel SLC37A4 Mutations in Korean Patients With Glycogen Storage Disease Ib","volume":"37","author":"Choi R","year":"2017","journal-title":"Ann Lab Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"28794","DOI":"10.1074\/jbc.M604964200","article-title":"Bone marrow-derived cells require a functional glucose 6-phosphate transporter for normal myeloid functions","volume":"281","author":"Kim SY","year":"2006","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1873-3468.13666","article-title":"Glycogen storage disease type Ib: role of glucose-6-phosphate transporter in cell metabolism and function","volume":"594","author":"Sim SW","year":"2020","journal-title":"FEBS Lett"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1182\/blood-2002-10-3128","article-title":"Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b)","volume":"101","author":"Kuijpers TW","year":"2003","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1007\/BF02680002","article-title":"Association of glycogen storage disease 1b and Crohn disease: results of a North American survey","volume":"161","author":"Dieckgraefe BK","year":"2002","journal-title":"Eur J Pediatr"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1182\/blood-2007-12-129114","article-title":"Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib","volume":"111","author":"Kim SY","year":"2008","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MOH.0000000000000474","article-title":"Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor","volume":"26","author":"Dale DC","year":"2019","journal-title":"Curr Opin Hematol"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani PS","year":"2014","journal-title":"Genetics in Medicine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"103767","DOI":"10.1016\/j.ejmg.2019.103767","article-title":"Impact of genotype on neutropenia in a large cohort of Serbian patients with glycogen storage disease type Ib","volume":"63","author":"Sarajlija A","year":"2019","journal-title":"Eur J Med Genet"},{"key":"ref18","first-page":"S120","article-title":"Consensus guidelines for management of glycogen storage disease type 1b - European Study on Glycogen Storage Disease Type 1","volume":"161","author":"Visser G","year":"2002","journal-title":"Eur J Pediatr"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12602-017-9372-9","article-title":"Effect of VSL#3 Probiotic in a Patient with Glycogen Storage Disease Type Ia and Irritable Bowel Disease-like Disease","volume":"11","author":"Carnero-Gregorio M","year":"2019","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref20","article-title":"Hepatic glycogen storage diseases are associated to microbial dysbiosis","volume":"14","author":"Colonetti K","year":"2019","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/metabo10040133","article-title":"Proteobacteria Overgrowth and Butyrate-Producing Taxa Depletion in the Gut Microbiota of Glycogen Storage Disease Type 1 Patients","volume":"10","author":"Ceccarani C","year":"2020","journal-title":"Metabolites"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1757-1626-1-418","article-title":"Splenic rupture, secondary to G-CSF use for chemotherapy induced neutropenia: a case report and review of literature","volume":"1","author":"Masood N","year":"2008","journal-title":"Cases J"},{"key":"ref23","article-title":"Spontaneous splenic rupture as a rare complication of G-CSF injection","volume":"2018","author":"Benguerfi S","year":"2018","journal-title":"BMJ Case Rep"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S8756-3282(02)00733-0","article-title":"Overexpression of granulocyte colony-stimulating factor induces severe osteopenia in developing mice that is partially prevented by a diet containing vitamin K2 (menatetrenone)","volume":"30","author":"Kokai Y","year":"2002","journal-title":"Bone"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","DOI":"10.1542\/peds.108.3.e54","article-title":"Severe osteopenia in a young boy with Kostmann\u2019s congenital neutropenia treated with granulocyte colony-stimulating factor: suggested therapeutic approach","volume":"108","author":"Sekhar RV","year":"2001","journal-title":"Pediatrics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/08880018.2018.1440675","article-title":"Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length","volume":"35","author":"Li AM","year":"2018","journal-title":"Pediatr Hematol Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1182\/blood-2005-11-4370","article-title":"The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy","volume":"107","author":"Rosenberg PS","year":"2006","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/8904_2015_461","article-title":"Vitamin E Improves Clinical Outcome of Patients Affected by Glycogen Storage Disease Type Ib","volume":"25","author":"Melis D","year":"2016","journal-title":"JIMD Rep"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood.2019004465","article-title":"Treating neutropenia and neutrophil dysfunction in glycogen storage disease IB with an SGLT2-inhibitor","volume":"136","author":"Wortmann SB","year":"2020","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.4049\/jimmunol.1601946","article-title":"Cutting Edge: Increased Autoimmunity Risk in Glycogen Storage Disease Type 1b Is Associated with a Reduced Engagement of Glycolysis in T Cells and an Impaired Regulatory T Cell Function","volume":"198","author":"Melis D","year":"2017","journal-title":"J Immunol"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ag\/v58n1\/1678-4219-ag-58-01-87.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T12:34:20Z","timestamp":1619181260000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032021000100087&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["S0004-28032021000100087"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.202100000-15","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]}}}